Evaluation of the Safety and Efficacy of the Cobra PzF NanoCoated Coronary Stent in Routine, Consecutive, Prospective, and High‐Risk Patients: The e‐Cobra Study | SCAI
Jun 17th 2020 | News & Clinical Trials

Evaluation of the Safety and Efficacy of the Cobra PzF NanoCoated Coronary Stent in Routine, Consecutive, Prospective, and High‐Risk Patients: The e‐Cobra Study

Acute Coronary Syndromes (ACS) Cardio-oncology CHIP/Complex PCI CTO Heart Failure Hemodynamic Support Hypertrophic Cardiomyopathy Left Main Bifurcation SIHD

From Catheterization & Cardiovascular Interventions

Authors: Luc Maillard, MD, PhD; Axel de Labriolle MD, PhD;  Camille Brasselet MD, PhD; Benjamin Faurie, MD; Nicolas Durel, MD; Fabien de Poli, MD; Sébastien Bosle, MD; Hend Madiot, CRA; Jacques Berland, MD; and Loic Belle MD.